Evidence map›Paper›PMID 29619741›Full record

ArticleMolecular neurobiology2018

Expression of miR-145 and Its Target Proteins Are Regulated by miR-29b in Differentiated Neurons.

Abhishek Jauhari, Tanisha Singh, Sanjay Yadav

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Epigenetic Dysregulation inInternational journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Retinoic acid and microRNA.Methods in enzymology · 2020
    Article
  11. Article
  12. DeregulatedCells · 2019
    Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Abhishek JauhariDevelopmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR- Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31 Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, -226001, India.
Tanisha SinghDevelopmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR- Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31 Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, -226001, India.
Sanjay YadavDevelopmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR- Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31 Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, -226001, India. sanjay@iitr.res.in.ORCID http://orcid.org/0000-0002-8245-8001
Indian Institute of Toxicology Research · INBabu Banarasi Das University · IN

Funding

CSIR mIND BSC-0115
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are emerging as the most potential regulator of neuronal development. Recent studies from our lab and elsewhere have demonstrated a direct role of miRNAs in regulating neuronal differentiation and synaptogenesis. MicroRNA-145, a miRNA identified to regulate pluripotency of stem cells, downregulates the protein levels of reprogramming transcription factors (RTFs) like OCT4, SOX2, and KLF4 (cell, 137,647-658,2009). Studies have shown that miR-145 is multifunctional and crucial for fate determination of neurons. In our recently published study, we have identified a set of miRNAs including miR-145 and miR-29b families differentially expressed in SH-SY5Y cells exposed sequentially with retinoic acid + brain-derived neurotrophic factor (RA+BDNF) for differentiation into mature neurons (Mol Neurobiol (2016) doi: https://doi.org/10.1007/s12035-016-0042-9 ). In the present study, we have identified the role of miR-29b in upregulation of miR-145, which is upregulated after exposure of RA+BDNF in a P53-dependent manner. In differentiating SH-SY5Y cells, expression of miR-29b downregulates expression of P85α, a P53 inhibitor, which results in upregulation of miR-145 and downregulation of RTF proteins. Ectopic expression of miR-145 and miR-29b in amounts equivalent to their endogenous expression has induced G1 phase cell cycle arrest. In conclusion, our studies have identified miR-29b as an upstream regulator of miR-145 and targets its RTF genes during differentiation of SH-SY5Y cells.

Indexed as

Cell DifferentiationGene Expression RegulationApoptosisCell Cycle CheckpointsCell Line, TumorClass Ia Phosphatidylinositol 3-KinaseG1 PhaseGene OntologyHumansKruppel-Like Factor 4MicroRNAsModels, BiologicalNeural Stem CellsNeuronsTranscription FactorsTumor Suppressor Protein p53Class Ia Phosphatidylinositol 3-KinaseKLF4 protein, humanKruppel-Like Factor 4MicroRNAsMIRN145 microRNA, humanMIRN29a microRNA, humanTranscription FactorsTumor Suppressor Protein p53KLF4MicroRNAsmiR-145miR-29bNANOGNeuronal differentiationOCT4P53,SH-SY5Y cellsReprogramming transcription factors (RTFs)SOX2

Identifiers

PMID29619741
OpenAlexW2795629221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.